secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mosaic ImmunoEngineering Inc. (CPMV)
CIK:        0000836564
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001683168-24-001813
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 1.02
LLM model:  deepseek-v4-flash:cloud@v2

CWRU terminates Mosaic's CPMV license for lead candidate MIE-101 over ~$407K unpaid IP fees
--------------------------------------------------------------------------------

- Effective March 22, 2024, CWRU terminated the exclusive worldwide license agreement due to financial default.
- Amount owed to CWRU increased to approximately $407,000 as of Dec. 31, 2023; company lacks capital to pay.
- Company evaluating strategic options including additional capital, M&A, or possible wind-down/liquidation.
- License was for foundational technology (CPMV) behind MIE-101, the sole immunotherapy candidate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/836564/000168316824001813/0001683168-24-001813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/836564/000168316824001813/mosaic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer